文献速递冠心病

轻度肾功能不全对多支血管冠脉血运重建患者的预后影响

Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization.
PubMed 文献 · J Am Coll Cardiol · 2022-01-01

基于Asan Medical Center-Multivessel Revascularization注册研究,10,354例接受冠脉血运重建的多支病变患者按eGFR分为肾功能正常(I期)、轻度不全(II期)和中度不全(III期)三组。倾向匹配后,I期与II期主要复合终点风险无显著差异(HR 1.12;95%CI 0.97-1.30),III期风险显著高于I期(HR 1.50;95%CI 1.22-1.84);各肾功能组中PCI与CABG的相对效应相似。

要点

  • 轻度肾功能不全(II期)与正常肾功能相比,主要复合终点风险无显著增加。
  • 中度肾功能不全(III期)主要复合终点风险显著高于正常肾功能。
  • 各肾功能组中PCI与CABG的主要终点比较结果相似。

核心结论

  • 多支血管病变血运重建后,轻度肾功能不全与主要复合终点及死亡风险增加无显著关联。
  • 在临界风险组中,PCI与CABG的比较结局相似。

研究设计与样本

  • 来自Asan Medical Center-Multivessel Revascularization注册研究(NCT02039752)的10,354例接受冠脉血运重建的合格患者。
  • 按估算肾小球滤过率分为3组:I期正常肾功能(n=3,735)、II期轻度不全(n=5,122)、III期中度不全(n=1,497)。
  • 主要终点为死亡、自发性心肌梗死或卒中的复合终点,采用倾向评分匹配构建基线特征相似的队列。

主要发现

  • 倾向匹配后,I期与II期主要复合终点风险无差异(HR 1.12;95%CI 0.97-1.30)。
  • III期主要终点风险显著高于I期(HR 1.50;95%CI 1.22-1.84)。
  • 在I、II、III期各肾功能组的匹配队列中,PCI与CABG对主要终点的相对效应相似。

临床怎么用

  • 多支血管病变血运重建决策时,轻度肾功能不全不应单独作为增加主要复合终点风险的依据。
  • 中度肾功能不全患者主要复合终点风险显著升高,需加强术后风险管理。
  • 轻度肾功能不全患者中PCI与CABG的 comparative 结局相似,血运重建方式选择可综合其他因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The long-term prognostic impact of mildly decreased renal function in patients undergoing coronary revascularization is still unknown. OBJECTIVES: The goal of this study was to investigate the long-term prognostic impact of mildly decreased renal function and comparative outcomes after percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) in such a risk group of patients. METHODS: From the Asan Medical Center-Multivessel Revascularization registry, 10,354 eligible patients who underwent coronary revascularization were classified into 3 groups (stage I [n = 3,735]: normal renal function; stage II [n = 5,122]: mild dysfunction; and stage III [n = 1,497]: moderate dysfunction) according to estimated glomerular filtration rate. The primary outcome was the composite of death, spontaneous myocardial infarction, or stroke. Propensity score matching was used to assemble a cohort of patients with similar baseline characteristics. RESULTS: After propensity matching, the risk for primary composite outcome was not different between the stage I and the stage II group (HR: 1.12; 95% CI: 0.97-1.30). However, the risk of the primary outcome was significantly higher in the stage III group than in the stage I group (HR: 1.50; 95% CI: 1.22-1.84). The relative effect of PCI vs CABG for the primary outcome was similar in the matched cohort of each renal function group of stages I, II, and III. CONCLUSIONS: In patients with multivessel disease after revascularization by PCI or CABG, the presence of mildly decreased renal function was not significantly associated with an increased risk of the primary composite outcome and mortality. Comparative outcomes after PCI and CABG were similar in the borderline-risk group. (Asan Medical Center-Multivessel Revascularization registry; NCT02039752).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Kim TO, Kang DY, Ahn JM, et al. Prognostic Impact of Mildly Impaired Renal Function in Patients Undergoing Multivessel Coronary Revascularization. J Am Coll Cardiol. 2022. PMID: 35361350. doi:10.1016/j.jacc.2022.01.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。